(1)
Validation of Reverse Phase High-Performance Liquid Chromatography Analytical Method for Osimertinib Mesylate and Its Degradation Products for Osimertinib Mesylate Tablets. Int. J. Pharm. Sci. Drug Res. 2022, 14 (6), 739-748. https://doi.org/10.25004/IJPSDR.2022.140611.